Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,127.1
-12.4 (-0.40%)

 

  • STI Straits Times Index
    3,127.1
    -12.4 (-0.40%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,578.3
    -
    Index delayed 15 minutes
  • HSI Hang Seng Index
    28,436.8
    -
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,518.3
    -
    Index delayed 15 minutes
  • N225 Nikkei 225
    29,022.2
    -268.8 (-0.92%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,078.6
    -
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1.2M
  • Value: 3.9M
  • Rise: -
  • Fall: -
  • Unch: 763

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
SinoCloud0.001-
Rex Intl0.198+0.008
OTS Holdings0.300+0.300
MarcoPolo Marine0.030-
ESR-REIT0.410-
Chasen0.069+0.005
Jiutian Chemical0.087-
Sembcorp Marine0.195-0.001
Hong Lai Huat0.105+0.008
Shen Yao0.008-

World Indices

World Indices
Name Last Change
Nasdaq 14,039.7 -33.2
HSI 28,436.8
HSCEI 10,563.0
Jakarta 6,078.6
Nikkei 225 28,999.0 -292.0
SSE Comp 3,518.3
Shanghai A 3,687.8
Shanghai B 252.8
KOSPI 3,256.2 -22.5

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

THERMOGENESIS HOLDINGS INC THERMOGENESIS HOLDINGS
Updated on 15 Jun 2021 (End of trading day)
Last (USD): 2.820 Change: -0.170 High: 3.020 Remarks: -
Change (%): -5.69 Low: 2.790
Open 3.020 Yesterday's Close 2.9899999999999998
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 136,260 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -1.37267 Trailing EPS (USD) e -1.18891 NAV (USD) b 0.8796
PE a - Trailing PE f - Price / NAV b 3.2060
Dividend (USD) d - Cash In Hand (USD) g 0.8407 Issued & Paid-up Shares c 11,911,800
Dividend Yield (%) d - Price / Cash In Hand g 3.354 Treasury Shares h -
Market Cap (M) 33.591 Enterprise Value (M) 31.589
Piotroski F Score 1 Exchange Code THMO Par Value ( $ ) n.a.
52 Weeks Volatility (%) 87.07 Free Float (%) 80.2
Sector & Industry Health Technology - Medical Specialties
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 19 Mar 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 01 Nov 2019.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference THERMOGENESIS HOLDINGS INC NASDAQ 33.591 - - 3.2060 -
Industry Medical Specialties NASDAQ 3,352.058 160.633 153.684 9.2312 0.026
Local Peer INTUITIVE SURGICAL INC NASDAQ 103,298.765 97.397 88.034 10.1737 -
Local Peer IDEXX LABORATORIES INC NASDAQ 50,508.347 86.817 74.915 71.8780 -
Local Peer ALIGN TECHNOLOGY INC NASDAQ 47,485.917 26.739 103.651 13.9929 -
Local Peer DEXCOM INC NASDAQ 39,175.560 79.367 76.217 20.5840 -
Local Peer GENMAB AS SPON ADS EACH REP 0.1 ORD SHS NASDAQ 28,886.232 39.701 33.881 9.0964 -
Local Peer NOVOCURE LTD NASDAQ 22,418.904 1,131.826 1,911.571 60.2445 -
Local Peer INSULET CORPORATION NASDAQ 18,406.826 2,706.851 2,068.183 31.4485 -
Local Peer HOLOGIC INC NASDAQ 16,004.313 14.351 8.392 4.2179 -
Local Peer DENTSPLY SIRONA INC NASDAQ 14,384.973 - 82.720 2.9196 0.608
Local Peer ABIOMED INC NASDAQ 13,666.709 60.599 60.600 10.2782 -
Local Peer MASIMO CORPORATION NASDAQ 12,352.540 51.404 53.887 9.3007 -
Local Peer BRUKER CORPORATION NASDAQ 11,418.623 72.361 55.974 11.7997 0.213
Other Local Peers STAAR SURGICAL CO (NASDAQ), SOTERA HEALTH CO (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), TANDEM DIABETES CARE INC (NASDAQ), ORTHO CLINICAL DIAGNOSTCS HLDGS PLC (NASDAQ), NEOGEN CORP (NASDAQ), QUIDEL CORP (NASDAQ), CAREDX INC (NASDAQ), INARI MEDICAL INC (NASDAQ), ICU MEDICAL INC (NASDAQ), LIVANOVA PLC (NASDAQ), ATRICURE INC (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), NUVASIVE INC (NASDAQ), INMODE LTD (NASDAQ), VERICEL CORP (NASDAQ), AXONICS INC (NASDAQ), HESKA CORP (NASDAQ), OUTSET MEDICAL INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), TREACE MED CONCEPTS INC (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), SINGULAR GENOMICS SYSTEMS INC (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), PULMONX CORPORATION (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), INOGEN INC (NASDAQ), EARGO INC (NASDAQ), MESA LABORATORIES INC (NASDAQ), NANO-X IMAGING LTD (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), DERMTECH INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), ATRION CORP (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), 908 DEVICES INC (NASDAQ), SI BONE INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), BIOVENTUS INC (NASDAQ), CERUS CORP (NASDAQ), NATUS MEDICAL INC (NASDAQ), ANGIODYNAMICS INC (NASDAQ), VIEWRAY INC (NASDAQ), AXOGEN INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), CUTERA INC (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), SURMODICS INC (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), ANTARES PHARMA INC (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), TALIS BIOMEDICAL CORP (NASDAQ), NEUROPACE INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), ZYNEX INC (NASDAQ), PAVMED INC (NASDAQ), SOLITON INC (NASDAQ), AVITA MEDICAL INC (NASDAQ), ONCOCYTE CORP (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), MEDAVAIL HOLDINGS INC (NASDAQ), ACUTUS MEDICAL INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), SIENTRA INC (NASDAQ), NEURONETICS INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), QUOTIENT LTD (NASDAQ), MISONIX INC (NASDAQ), CLEARPOINT NEURO INC (NASDAQ), PROFOUND MED CORP (NASDAQ), IRADIMED CORP (NASDAQ), CYTOSORBENTS CORP (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), DARIOHEALTH CORP (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), CORMEDIX INC (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), CONFORMIS INC (NASDAQ), SURGALIGN HOLDINGS INC (NASDAQ), INTRICOM CORP (NASDAQ), LUCIRA HEALTH INC (NASDAQ), MYMD PHARMACEUTICALS INC (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), TELA BIO INC (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD (NASDAQ), TITAN MEDICAL INC (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), VENUS CONCEPT INC (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), FONAR CORP (NASDAQ), IRIDEX CORP (NASDAQ), CHECK-CAP LTD (NASDAQ), CELSION CORPORATION (NASDAQ), BIOLASE INC (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), AVINGER INC (NASDAQ), LENSAR INC (NASDAQ), NEPHROS INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), APPLIED UV INC (NASDAQ), ELECTROCORE INC (NASDAQ), AETHLON MEDICAL INC (NASDAQ), IMMUCELL CORP (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), NEOVASC INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), HANCOCK JAFFE LABORATORIES INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), PREDICTIVE ONCOLOGY INC (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), BIOMERICA INC (NASDAQ), INSPIREMD INC (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), OBALON THERAPEUTICS INC (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), NUWELLIS INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), DYNATRONICS CORP (NASDAQ), CYANOTECH CORP (NASDAQ), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), STAR EQUITY HOLDINGS INC (NASDAQ), NEUROMETRIX INC (NASDAQ)
Global Peer ABBOTT LABORATORIES NYSE 196,178.696 43.858 34.441 5.8453 1.381
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 184,754.602 28.981 23.316 5.2700 0.189
Global Peer DANAHER CORP NYSE 174,824.683 49.808 49.808 4.7058 0.293
Global Peer MEDTRONIC PLC NYSE 168,403.718 46.701 46.701 3.2745 1.853
Global Peer STRYKER CORP NYSE 96,703.677 60.478 68.682 7.1622 0.916
Global Peer BECTON DICKINSON & CO NYSE 70,215.339 91.545 42.814 2.8285 1.322
Global Peer EDWARDS LIFESCIENCES CORP NYSE 62,337.758 75.708 73.252 13.3817 -
Global Peer BOSTON SCIENTIFIC CORP NYSE 60,743.902 - 424.783 3.8644 -
Global Peer MICROPORT HKEx 112,158.995 - - 12.8240 0.069
Global Peer FISHER & PAYKEL HEALTHCARE CORP ASX 16,387.420 33.479 33.479 11.7177 1.468
Other Global Peers COCHLEAR LTD (ASX), QIAGEN NV (NYSE), PENUMBRA INC (NYSE), WEIGAO GROUP (HKEx), TOPGLOV (Bursa), Top Glove (SGX), HILL-ROM HOLDINGS INC (NYSE), GLOBUS MED INC (NYSE), ENVISTA HOLDINGS CORPORATION (NYSE), HARTA (Bursa), NEVRO CORP (NYSE), INSPIRE MEDICAL SYSTEMS INC (NYSE), CARDIOFLOW-B (HKEx), EBOS GROUP (ASX), CONMED CORP (NYSE), VENUS MEDTECH-B (HKEx), GLAUKOS CORPORATION (NYSE), HAEMONETICS CORP (NYSE), LIFETECH SCI (HKEx), PEIJIA-B (HKEx), SUPERMX (Bursa), BUTTERFLY NETWORK INC (NYSE), AVANOS MEDICAL INC (NYSE), KANGJI MEDICAL (HKEx), AK MEDICAL (HKEx), NANOSONICS LIMITED (ASX), CIRC (HKEx), CHUNLI MEDICAL (HKEx), CRYOLIFE INC (NYSE), MODERN DENTAL (HKEx), INFUSYSTEM HOLDINGS INC (NYSE American), KDL MEDICAL (HKEx), BASECARE-B (HKEx), STEREOTAXIS INC (NYSE American), VAPOTHERM INC (NYSE), MCP INCOME OPPORTUNITIES TRUST (ASX), Medtecs Intl (SGX), RETRACTABLE TECHNOLOGIES INC (NYSE American), YESTAR HEALTH (HKEx), INVACARE CORP (NYSE), UGHealthcare (SGX), MEDICAL DEVELOPMENT INTL (ASX), AROA BIOSURGERY LTD (ASX), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), INCANNEX HEALTHCARE LTD (ASX), CYCLOPHARM LIMITED (ASX), PW MEDTECH (HKEx), EMVISION MEDICAL DEVICES LTD (ASX), VINCENT MED (HKEx), SOMNOMED LIMITED (ASX), OPTISCAN IMAGING (ASX), IMPEDIMED LIMITED (ASX), ALPHA PRO TECH (NYSE American), MICRO-X LTD (ASX), KELFRED (HKEx), CLEANSPACE HOLDINGS LTD (ASX), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), VOLITIONRX LIMITED (NYSE American), IMAGION BIOSYSTEMS LIMITED (ASX), ELECTROMED INC (NYSE American), SDI LTD (ASX), ATOMO DIAGNOSTICS LIMITED (ASX), MILESTONE SCIENTIFIC INC (NYSE American), CARDIEX LTD (ASX), RGTBHD (Bursa), YUNNAN ENERGY (HKEx), RESONANCE HEALTH LTD (ASX), Biolidics (SGX), ADVENTA (Bursa), COMPUMEDICS (ASX), DAXOR CORP (NYSE American), RESPIRI LTD (ASX), LKL (Bursa), DIMERIX LTD (ASX), NOVA EYE MEDICAL LIMITED (ASX), RESAPP HEALTH LIMITED (ASX), XTANT MEDICAL HLDGS INC (NYSE American), Yunnan Energy (SGX), ADHERIUM LIMITED (ASX), NEUROTECH INTERNATIONAL LTD (ASX), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), LIFE HEALTHCARE (HKEx), ALLEGRA ORTHOPAEDICS LIMITED (ASX), TRUSCREEN GROUP LTD (ASX), LBT INNOVATIONS LTD (ASX), USCOM LTD (ASX), OVENTUS MEDICAL LTD (ASX), RA MEDICAL SYSTEMS INC (NYSE American), METALICITY LIMITED (ASX), Annica (SGX), DORSAVI LTD (ASX), ANALYTICA (ASX), HUAKANG BIOMED (HKEx), STHAI (SET)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.070
-2.42 %
10 Days -+0.040
+1.44 %
20 Days -+0.500
+21.55 %
Medium Term Return 3 Months --0.210
-6.93 %
6 Months -+0.660
+30.56 %
1 Year --3.030
-51.79 %
Annualised Return Annualised --
-51.79 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 1.920 - 7.500 Change From 1 Year Low +0.900 % Change From 1 Year Low (%) +46.88
Change From 1 Year High -4.680 % Change From 1 Year High (%) -62.40
2 Years Range 1.630 - 14.180 Change From 2 Years Low +1.190 % Change From 2 Years Low (%) +73.01
Change From 2 Years High -11.360 % Change From 2 Years High (%) -80.11
5 Years Range 1.630 - 14.180 Change From 5 Years Low +1.190 % Change From 5 Years Low (%) +73.01
Change From 5 Years High -11.360 % Change From 5 Years High (%) -80.11
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

ThermoGenesis Holdings, Inc. engages in the research, development, commercialization, and marketing of automated cell processing technologies for the cell and gene therapy field. It operates through the Device and Clinical Development segment. The Device segment includes the development and commercialization of automated technologies for cell-based therapeutics and bioprocessing. The Clinical Development segment utilizes autologous stem cell-based therpeutics. The company was founded by Philip H. Coelho in 1986 and is headquartered in Rancho Cordova, CA.

Historical Price Data

Date Open High Low Close Volume VWAP
15 Jun 2021 3.020 3.020 2.790 2.820 136,260 -
14 Jun 2021 2.950 3.050 2.900 2.990 254,654 -
11 Jun 2021 2.920 2.940 2.860 2.940 54,857 -
10 Jun 2021 2.857 2.900 2.780 2.870 76,029 -
09 Jun 2021 2.880 2.970 2.860 2.890 185,571 -
08 Jun 2021 2.770 2.920 2.760 2.850 178,931 -
07 Jun 2021 2.790 2.800 2.700 2.770 75,485 -
04 Jun 2021 2.720 2.800 2.720 2.750 77,198 -
03 Jun 2021 2.690 2.800 2.690 2.720 113,575 -
02 Jun 2021 2.740 2.870 2.680 2.780 365,145 -
01 Jun 2021 2.790 2.850 2.670 2.760 241,541 -
28 May 2021 2.740 2.820 2.690 2.740 186,828 -
27 May 2021 2.590 2.720 2.520 2.670 457,298 -
26 May 2021 2.510 2.610 2.470 2.600 115,031 -
25 May 2021 2.600 2.620 2.410 2.510 661,855 -
24 May 2021 2.450 2.570 2.400 2.540 1,118,838 -
21 May 2021 2.360 2.480 2.332 2.400 286,339 -
20 May 2021 2.360 2.500 2.320 2.370 332,650 -
19 May 2021 2.370 2.420 2.240 2.320 434,719 -
18 May 2021 2.220 2.440 2.170 2.400 321,529 -
17 May 2021 2.170 2.248 2.150 2.200 137,884 -
14 May 2021 2.390 2.390 2.130 2.150 460,094 -
Summary
Current 2 Weeks
(02 Jun 2021 to 15 Jun 2021)
2.740 3.050 2.680 2.820 1,517,705 -
Previous 2 Weeks
(18 May 2021 to 01 Jun 2021)
2.220 3.050 2.170 2.760 4,156,628 -
4 Weeks from
(20 Apr 2021 to 17 May 2021)
2.460 3.050 2.360 2.200 6,500,982 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.